What Is The Social Security Shortfall?
Today, the
What Is The Social Security Shortfall?
Today, the discussion of Social Security's long-term financial challenges is pretty much limited to when the consequences arrive rather than how we will manage them when they arrive.
These consequences are generally expressed in terms of the unfunded liability, or "financing shortfall". While these outcomes are dire and getting worse every year, the public debate about Social Security Opens a New Window. reform suggests that these measures are not completely understood.
The "unfunded liability" represents the amount of money that the government would need to invest today in order to reasonably expect Social Security to operate over a specific timeframe. The calculation of the figure converts the difference between projected revenue and expected expense into a present value. For example, if the experts believe that Social Security Opens a New Window. will spend $1 more than it will collect in 2086, the math would add roughly $0.15 to the total because that amount invested today will grow into $1 in 2086.
Generally, the shortfall is expressed over 75 years, roughly the time to get all voting-aged Americans through the system. According to the Social Security Trustees Report for 2016, the present value of the financing gaps over that period equals $11.4 trillion Opens a New Window. . So if we add that amount of money today, the system should function for 75 years. In year 76, the system would be just as troubled as it is today.
While many pundits use unfunded liabilities in definitive terms, the calculation is not an exact science. The figure is a ballpark warning of what should happen in a normal economy if we do nothing.
If $11.4 trillion sounds unpleasant, you need to understand that the 75-year projection is fundamentally flawed because the concept does not truly reflect the actual mechanics of Social Security Opens a New Window. . The math tends to understate the actual problem.
Social Security is a financed program. Every dollar that comes into the program creates promises of future benefits for the worker who made the contribution. Conceptually, this is no different from going to a bank to borrow money in the form of a loan. Unfortunately, the 75-year projection shows the unfunded obligation of Social Security as though the "loan" payments due in the 76th year and afterward do not exist.
There is no free lunch in Social Security Opens a New Window. . This reality is demonstrated by the projections Opens a New Window. for expanding the coverage of Social Security to nearly 5 million state and local workers. Yes, the current taxes paid by the new workers would improve the near-term finances. The system would however be worse off by the 75th year due to the benefits that would be paid to these new workers in retirement.
The second weakness of the 75-year calculation is affected by the passage of time. The trustees reported in the 2016 report that solely changing the valuation date would have added $500 billion Opens a New Window. to the unfunded liabilities of the program. That is a lot for a program that only collects $800 billion in total.
Part of the increased cost comes from the discounting process in which we have one less year to discount. Over the past year, the $1 gap for 2086 has grown from $0.15 (2015 $s) to $0.16 (2016 $s). In other words, the unfunded liabilities grow just like debt that accrues a normal rate of interest.
The rest of the cost comes from changing the timeframe. Over the past year, the definition of solvency changed to the period from 2016 to 2090. So the valuation has replaced 2015 – a year with a modest surplus – with 2090 – a year with a large shortfall.
In conjunction, we can add $11.4 trillion to Social Security Opens a New Window. , and the system will meet the definition of solvency for a year. The next year it likely will not. Time is the Achilles Heel of Social Security, much more so than demographics. The difference is demographic forces may from time to time make the system better off, but time never will.
Today the discussion of Social Security is limited to the length of the fuse. Virtually no one is talking about the increasing size of the bomb.
Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP
Scroll down for more posts ▼
Top 10 Most Recent News Articles
A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...
Continue Reading
Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...
Continue Reading
You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...
Continue Reading
Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...
Continue Reading
AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...
Continue Reading
History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...
Continue Reading
Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....
Continue Reading
Top 5 Most Recently Viewed Articles
Quaker Chemical Faces Significant Market Challenges In a challenging market climate, Quaker Chemical Corporation (NYSE: KWR) recently saw its stock plummet to a 52-week low of $138.97. This specialty chemical company, renowned for its high-performance process fluids and coatings utilized in metalworking, has undergone considerable struggles over the past year, leading to...
Continue Reading
Aura Minerals Completes Acquisition of Bluestone Resources Aura Minerals Inc. (TSX: ORA) has successfully executed its acquisition of Bluestone Resources Inc. (BBSRF) through a strategic arrangement. This transaction signals a notable expansion for Aura as it aims to enhance its precious metals portfolio. Terms of the Acquisition Under the recent agreement, shareholders...
Continue Reading
Employee Benefits Marketing Transformation In the landscape of employee benefits, there lies a pressing need for innovation, especially regarding effective communication and marketing engagement. Businessolver, a recognized leader in HR and benefits technology, has taken significant strides with the introduction of its Benefits Communication and Automation Engine. This...
Continue Reading
Middlefield Canadian Income PCC Overview Middlefield Canadian Income PCC is a distinct investment option that focuses on providing income opportunities. Established as a protected cell company in Jersey, it adheres to well-defined regulatory standards, adding a layer of security for those who invest in it. Net Asset Value Insights In a recent evaluation, the estimated...
Continue Reading
Tarsus Pharmaceuticals Engages in Important Healthcare Conference Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) is committed to meeting unmet medical needs through innovative scientific advancements and cutting-edge technology. The company places a strong emphasis on eye care, with the goal of transforming the treatment landscape for patients. Recently, Tarsus announced...
Continue Reading